Ann: Jayex subsidiary completes cannabis licensing inspection, page-13

i am hoping for 4 things here:

1. quarterly cash flow includes a note about the cash component to be received from the recent divestment of now non-core business segment, demonstrating a healthier cash balance overall

2. updated medical cannabis strategy will be announced soon

3. current technologies including apps and dispenser can be put to good use to generate revenue and growth; similarly, any partnerships should be generating revenue or cancelled

4. plans are underway to action the strategy and expand even further in the cannabis sector, including wider priduct offering and geographically

fully diluted market cap is currently a mere 13,000,000 aud, giving a lot of room for share price appreciation